From: A prediction model for worsening diabetic retinopathy after panretinal photocoagulation
Variables | Total patients (n = 271) | DR-worsening (n = 153) | Non-DR-worsening (n = 118) | P valuea |
---|---|---|---|---|
Age, years | 50.69 ± 11.24 | 49.16 ± 10.90 | 52.66 ± 11.42 | 0.011* |
Male, n (%) | 158 (58.30%) | 95 (62.1%) | 63 (53.4%) | 0.150 |
Baseline BCVA (logMAR) | 0.30 (0.10, 0.52) | 0.40 (0.22, 0.70) | 0.22 (0.10, 0.40) |  < 0.001** |
Diabetes duration, years | 12.24 ± 7.37 | 11.92 ± 7.26 | 12.64 ± 7.52 | 0.524 |
Type 2 diabetes, n (%) | 261 (96.31%) | 145 (94.8%) | 116 (98.3%) | 0.127 |
PDR, n (%) | 169 (62.36%) | 98 (64.1%) | 71 (60.2%) | 0.324 |
Diabetic nephropathy, n (%) | 72 (26.57%) | 65 (42.5%) | 7 (5.9%) |  < 0.001** |
Diabetic neuropathy, n (%) | 22 (8.12%) | 19 (12.4%) | 3 (2.5%) | 0.003** |
Coronary heart disease, n (%) | 24 (8.86%) | 17 (11.1%) | 9 (7.6%) | 0.335 |
Prior Stroke, n (%) | 14 (5.17%) | 8 (5.2%) | 6 (5.1%) | 0.958 |
Hyperlipidemia, n (%) | 75 (27.68%) | 59 (38.6%) | 16 (13.6%) |  < 0.001** |
Hypertension, n (%) | Â | Â | Â | Â |
0 | 71 (26.20%) | 40 (26.1%) | 31 (26.3%) | 0.111 |
1 | 83 (30.63%) | 41 (26.8%) | 42 (35.6%) | |
2 | 48 (17.71%) | 23 (15.0%) | 25 (21.2%) | |
3 | 69 (25.46%) | 49 (32.0%) | 20 (16.9%) | |
BMI, kg/m2 | 25.52 ± 3.42 | 25.46 ± 3.67 | 25.60 ± 3.09 | 0.732 |
Homocysteine, umol/L | 13.34 ± 7.91 | 14.14 ± 9.40 | 12.29 ± 5.27 | 0.061 |
Fasting blood glucose, mmol/L | 6.96 ± 2.77 | 7.18 ± 2.81 | 6.67 ± 2.71 | 0.085 |
Urea, umol/L | 6.66 ± 3.86 | 7.58 ± 4.78 | 5.47 ± 1.47 |  < 0.001** |
Creatinine, mmol/L | 71.40 (56.70, 92.50) | 76.20 (61.15, 110.50) | 66.30 (54.83, 79.75) |  < 0.001** |
Uric acid, umol/L | 327.98 ± 90.23 | 340.59 ± 89.91 | 311.64 ± 88.37 | 0.009** |
Total cholesterol, mmol/L | 4.36 ± 1.18 | 4.49 ± 1.36 | 4.18 ± 0.89 | 0.090 |
Triglyceride, mmol/L | 1.18 (0.88, 1.75) | 1.27 (0.87, 1.98) | 1.15 (0.89, 1.57) | 0.139 |
High-density lipoprotein, mmol/L | 1.13 ± 0.34 | 1.13 ± 0.35 | 1.12 ± 0.32 | 0.92 |
Low-density lipoprotein, mmol/L | 2.76 ± 0.97 | 2.82 ± 1.10 | 2.67 ± 0.78 | 0.281 |
Serum superoxide dismutase, U/ML | 146.23 ± 27.01 | 144.44 ± 30.87 | 148.56 ± 20.87 | 0.076 |
Glycosylated serum protein, umol/L | 228.91 ± 75.04 | 228.53 ± 82.28 | 229.39 ± 64.80 | 0.986 |
Serum cystatin C, mg/L | 1.04 (0.87, 1.27) | 1.11 (0.89, 1.41) | 0.97 (0.86, 1.11) |  < 0.001** |
Hemoglobin, g/L | 129.58 ± 18.91 | 127.04 ± 20.54 | 132.88 ± 16.07 | 0.044* |
Hematocrit | 0.38 ± 0.05 | 0.37 ± 0.06 | 0.39 ± 0.04 | 0.026* |
Platelet, 109/L | 215.19 ± 61.32 | 213.56 ± 64.11 | 217.31 ± 57.69 | 0.613 |
Neutrophil/lymphocyte ratio | 1.91 (1.47, 2.57) | 1.97 (1.53, 2.76) | 1.81 (1.39, 2.25) | 0.017* |